Back
Hyatt Hotels Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
66
H
Hyatt Hotels
Last Price:
158.14
Seasonality Move:
11.83%
Buy
58
SRPT
Sarepta Therapeutics
Last Price:
133.49
Seasonality Move:
14.88%
Buy
66
Hyatt Hotels (H)
is a Buy
Is Hyatt Hotels a Buy, Sell or Hold?
- The current Hyatt Hotels [H] share price is $157.94. The Score for H is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- H is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
H Stock Price Chart
What is Hyatt Hotels's stock price today?
-
The Hyatt Hotels share price today is $157.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and H is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $133.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
H Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.38 | Buy |
Relative Strength Index (14 RSI): | 56.13 | Buy |
Chaikin Money Flow: | 110024 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (149.35 - 158.85) | Buy |
Bollinger Bands (100): | (143.26 - 156.68) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.78 | Buy |
Relative Strength Index (14 RSI): | 63.54 | Buy |
Chaikin Money Flow: | -725343 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.85 - 129.81) | Buy |
Bollinger Bands (100): | (119.21 - 141.67) | Buy |
H Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 156.38 | Buy |
20-day SMA: | 154.11 | Buy |
50-day SMA: | 153.62 | Buy |
200-day SMA: | 150.26 | Buy |
8-day EMA: | 156.61 | Buy |
20-day EMA: | 155.21 | Buy |
50-day EMA: | 153.12 | Buy |
200-day EMA: | 146.04 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 119.83 | Buy |
20-day SMA: | 118.14 | Buy |
50-day SMA: | 122.33 | Buy |
200-day SMA: | 130.09 | Buy |
8-day EMA: | 123.82 | Buy |
20-day EMA: | 120.48 | Buy |
50-day EMA: | 122.96 | Buy |
200-day EMA: | 126.17 | Buy |
Hyatt Hotels Earnings Growth & H Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.66 per share, and a decrease next year of $0.01 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.
Hyatt Hotels Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |